Date published: 2026-4-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

Fluphenazine-N-2-chloroethane·2HCl (CAS 83016-35-7)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
SKF-7171A
Application:
Fluphenazine-N-2-chloroethane⋅2HCl is an irreversible CaM, D1DR and D2DR blocker
CAS Number:
83016-35-7
Purity:
98%
Molecular Weight:
528.89
Molecular Formula:
C22H25ClF3N3S•2HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Fluphenazine-N-2-chloroethane is a nitrogen mustard-containing derivative of Fluphenazine dihydrochloride (sc-211531) that demonstrates irreversible inhibition of CaM-induced activation of CNPase (cyclic nucleotide phosphodiesterase). Inclusion of the alkylating nitrogen mustard moiety in Fluphenazine-N-2-chloroethane produces irreversible deactivation of CaM, while the parent compound demonstrates a reversible inhibitory activity. CaM antagonism is shown to sensitize malignant cells to TRAIL (tumor necrosis factor related apoptosis-inducing ligand) necrotic signaling, promoting cell death in TRAIL-resistant growth. Fluphenazine-N-2-chloroethane is further shown to irreversibly antagonize dopamine receptors with selectivity for D2DR over D1DR. Inhibition of the dopamine receptors by Fluphenazine-N-2-chloroethane correlated to an increase in D2DR mRNA, a decrease in D1DR mRNA, and an increase in glutamic acid decarboxylase mRNA, indicating that this inhibition of dopamine receptor activity has a regulatory role in the cellular expression of dopaminergic and GABAergic proteins.


Fluphenazine-N-2-chloroethane·2HCl (CAS 83016-35-7) References

  1. Calmodulin inhibition contributes to sensitize TRAIL-induced apoptosis in human lung cancer H1299 cells.  |  Hwang, MK., et al. 2009. Biochem Cell Biol. 87: 919-26. PMID: 19935877
  2. Differential effects of fluphenazine-N-mustard, on calmodulin activity and on D1 and D2 dopaminergic responses.  |  Winkler, JD., et al. 1987. Psychopharmacology (Berl). 92: 285-91. PMID: 2957717
  3. Dual action of ketamine confines addiction liability.  |  Simmler, LD., et al. 2022. Nature. 608: 368-373. PMID: 35896744
  4. Pharmacological properties of fluphenazine-mustard, an irreversible calmodulin antagonist.  |  Hait, WN., et al. 1987. Mol Pharmacol. 32: 404-9. PMID: 3670276
  5. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.  |  Qin, ZH., et al. 1995. Mol Pharmacol. 48: 730-7. PMID: 7476901
  6. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.  |  Chen, JF., et al. 1994. Neurochem Int. 25: 355-66. PMID: 7820070
  7. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum.  |  Chen, JF. and Weiss, B. 1993. Neurosci Lett. 150: 215-8. PMID: 8097031

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Fluphenazine-N-2-chloroethane·2HCl, 50 mg

sc-201502
50 mg
$67.00